Professor of Clinical Neuroscience at the Neurology Research and Clinical Trials Unit of the Peninsula Medical School at the University of Plymouth
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
"I very much welcome any potential change to the law, providing the results of the clinical trials are positive. Some patients have already reported an improvement in pain but it is too early to draw any conclusions...
If we are to provide the evidence that the drug is useful in alleviating pain in MS then there has to be a way of getting the drug to those patients. Changes in the classification of cannabis would help for that to be achieved and that is a good thing."
"Medicinal Cannabis Set to be Legalised" Oct. 23, 2001
Experts PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Professor of Clinical Neuroscience, Neurology Research and Clinical Trials Unit, Peninsula Medical School, University of Plymouth, UK
Consultant Neurologist, Derriford Hospital, Plymouth, UK
Principle Investigator, Cannabinoids in Multiple Sclerosis (CAMS)
Principle Investigator, South West Impact of Multiple Sclerosis (SWIMS)
PhD, School unknown
Fellowship of the Royal College of Physicians (FRCP)
Phone: 01752-777111 ext. 54376 Fax: None found Email: None found Website:Faculty Page
Co-author, "The Effect of Cannabis on Urge Incontinence in Patients with Multiple Sclerosis: A Multicentre, Randomised Placebo-controlled Trial," International Urogynecology Journal and Pelvic Floor Dysfunction, 2006
Co-author, "The Use of Cannabinoids in Multiple Sclerosis," Expert Opinion on Investigational Drugs, 2005
Co-author, "Cannabinoid Influence on Cytokine Profile in Multiple Sclerosis," Clinical and Experimental Immunology, 2005
Co-author, "The Effect of Cannabis on Tremor in Patients with Multiple Sclerosis," Neurology, 2004